Eversept Partners as of June 30, 2019
Portfolio Holdings for Eversept Partners
Eversept Partners holds 64 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| R1 Rcm | 9.6 | $34M | 2.7M | 12.58 | |
| Amarin Corporation | 8.5 | $30M | 1.6M | 19.39 | |
| GlaxoSmithKline | 7.9 | $28M | 694k | 40.50 | |
| Zogenix | 7.2 | $26M | 537k | 47.78 | |
| Danaher Corporation (DHR) | 5.9 | $21M | 145k | 143.08 | |
| Ensign (ENSG) | 4.9 | $17M | 306k | 56.97 | |
| Radius Health | 4.9 | $17M | 711k | 24.36 | |
| Ascendis Pharma A S (ASND) | 4.4 | $16M | 136k | 115.15 | |
| eHealth (EHTH) | 4.3 | $15M | 179k | 86.10 | |
| Sanofi-Aventis SA (SNY) | 3.2 | $12M | 266k | 43.27 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.0 | $11M | 58k | 183.37 | |
| Tg Therapeutics (TGTX) | 2.2 | $7.6M | 884k | 8.65 | |
| Deciphera Pharmaceuticals | 1.9 | $6.9M | 305k | 22.55 | |
| Argenx Se (ARGX) | 1.9 | $6.8M | 48k | 141.58 | |
| Illumina (ILMN) | 1.9 | $6.7M | 18k | 368.12 | |
| Alnylam Pharmaceuticals (ALNY) | 1.8 | $6.3M | 87k | 72.56 | |
| Audentes Therapeutics | 1.7 | $6.0M | 160k | 37.86 | |
| NuVasive | 1.5 | $5.4M | 92k | 58.54 | |
| Centene Corporation (CNC) | 1.5 | $5.2M | 100k | 52.44 | |
| ArQule | 1.4 | $5.0M | 452k | 11.01 | |
| Fate Therapeutics (FATE) | 1.2 | $4.4M | 218k | 20.30 | |
| Arena Pharmaceuticals | 1.2 | $4.3M | 74k | 58.63 | |
| Zogenix Inc call | 1.2 | $4.2M | 1.0k | 4040.27 | |
| Dermira | 1.1 | $3.8M | 400k | 9.56 | |
| Tricida | 1.0 | $3.5M | 88k | 39.46 | |
| Macrogenics (MGNX) | 0.9 | $3.2M | 191k | 16.97 | |
| Heska Corporation | 0.8 | $3.0M | 35k | 85.16 | |
| Apellis Pharmaceuticals (APLS) | 0.8 | $3.0M | 117k | 25.34 | |
| Anthem (ELV) | 0.8 | $2.8M | 10k | 282.20 | |
| Myokardia | 0.8 | $2.8M | 57k | 50.15 | |
| Humana (HUM) | 0.8 | $2.7M | 10k | 265.80 | |
| Sarepta Therapeutics (SRPT) | 0.7 | $2.5M | 17k | 151.93 | |
| Genomic Health | 0.6 | $2.2M | 38k | 58.17 | |
| Ptc Therapeutics I (PTCT) | 0.6 | $2.2M | 49k | 45.00 | |
| Xenon Pharmaceuticals (XENE) | 0.6 | $2.2M | 224k | 9.86 | |
| Medicines Company | 0.6 | $2.1M | 57k | 36.47 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.5 | $1.9M | 141k | 13.15 | |
| BioDelivery Sciences International | 0.5 | $1.7M | 356k | 4.65 | |
| Teligent | 0.5 | $1.6M | 2.6M | 0.63 | |
| Sabra Health Care REIT (SBRA) | 0.4 | $1.5M | 79k | 19.69 | |
| Omega Healthcare Investors (OHI) | 0.4 | $1.5M | 41k | 36.74 | |
| LTC Properties (LTC) | 0.4 | $1.5M | 33k | 45.66 | |
| Caretrust Reit (CTRE) | 0.4 | $1.5M | 63k | 24.00 | |
| BioCryst Pharmaceuticals (BCRX) | 0.4 | $1.3M | 343k | 3.79 | |
| Invacare Corporation | 0.3 | $1.1M | 210k | 5.19 | |
| Affimed Therapeutics B V | 0.3 | $925k | 322k | 2.87 | |
| Provention Bio | 0.2 | $891k | 74k | 12.10 | |
| Eiger Biopharmaceuticals | 0.2 | $739k | 70k | 10.60 | |
| Optinose | 0.2 | $744k | 105k | 7.08 | |
| Akorn | 0.2 | $678k | 132k | 5.15 | |
| Dicerna Pharmaceuticals | 0.2 | $647k | 41k | 15.75 | |
| Foamix Pharmaceuticals | 0.2 | $627k | 263k | 2.38 | |
| Cymabay Therapeutics | 0.2 | $604k | 84k | 7.17 | |
| Albireo Pharma | 0.2 | $581k | 18k | 32.23 | |
| Savara (SVRA) | 0.2 | $574k | 242k | 2.37 | |
| Scpharmaceuticals (SCPH) | 0.2 | $556k | 174k | 3.19 | |
| Otonomy | 0.1 | $535k | 194k | 2.75 | |
| Pfenex | 0.1 | $546k | 81k | 6.74 | |
| Cyclerion Therapeutics | 0.1 | $217k | 19k | 11.47 | |
| Aquinox Pharmaceuticals | 0.1 | $174k | 74k | 2.36 | |
| Zogenix Inc put | 0.0 | $54k | 364.00 | 148.35 | |
| BIOCRYST PHARMACEUTICALS INC CMN Stk cmn | 0.0 | $30k | 1.0k | 29.47 | |
| Celgene Corp right 12/31/2011 | 0.0 | $4.0k | 6.0k | 0.67 | |
| Concert Pharmaceuticals Inc call | 0.0 | $1.0k | 23.00 | 43.48 |
